Hemodialysis and Peritoneal Dialysis Market

Nadan Niazi

December 5, 2022

152

Read Time:7 Minute, 50 Second

Hemodialysis and Peritoneal Dialysis Market

Hemodialysis and Peritoneal Dialysis Market to Reach USD 148.4 Billion by 2031, driven by the growth in investment in healthcare infrastructure across the globe: Global Insight Services

New York, August 2022: According to a new research study by Global Insight Services (GIS), the global hemodialysis and peritoneal dialysis market is expected to grow rapidly over the next 10 years to reach a value of more than USD 148.4 billion by 2031.

Dialysis is a procedure used to remove waste products from the blood, such as urea and creatinine, which are caused by the kidneys’ improper functioning and are typically necessary for those with chronic renal failure. Hemodialysis and peritoneal dialysis are the two types of this treatment used to treat renal problems. Hemodialysis involves pumping blood out of blood vessels, purifying it with a dialyzer, and then reintroducing it to the body via vascular access. The basic idea behind the process is the same as peritoneal dialysis, except the peritoneum, the inner lining of the stomach, is utilized as a filter to clean the blood.

Request Sample Pages of this Research Report: https://www.globalinsightservices.com/request-sample/GIS10293/

Hemodialysis and Peritoneal Dialysis Market: Key Trends and Drivers

The demand for hemodialysis and peritoneal dialysis is being driven by a number of factors, including the increasing prevalence of acute kidney injury (AKI), a lack of organ donors, the risks associated with transplants, technological advancements, and initiatives by the major players to introduce cutting-edge products and services. Additionally, the COVID-19 pandemic outbreak has increased the need for dialysis significantly around the world. As a result, the industry has seen increased financial incentives and regulatory support from several government agencies. Throughout the projected period, these elements are anticipated to support the market’s expansion.

Furthermore, it is anticipated that the need for home care dialysis services would continue to rise. Acute and chronic kidney disease patients are treated at home or in outpatient settings. As a result, there is a greater need for renal home treatments. In addition, the NCBI reports that, as of 2017, 10.8% of Americans used home dialysis, a 30 percent rise over the previous ten years. The Advancing Kidney Health Initiative made the suggestion in 2019 to treat more patients with renal failure at home using hemodialysis or peritoneal dialysis. In addition, CMS suggested a target of having 80% of dialysis patients get their care in a home environment.

Hemodialysis and Peritoneal Dialysis Market: Restraints and Challenges

Increased dialysis-related side effects including infections, hypotension, fluid overload, and access point hemorrhage are projected to restrain market expansion in the years to come. Similar issues with reimbursement policies in developing countries limit market expansion. This is explained by the fact that compensation for dialysis varies significantly in terms of quantity and duration between different nations and does not always account for actual treatment expenses, which discourages patients and doctors from thinking about how to use the policy.

Hemodialysis and Peritoneal Dialysis Market Report Findings https://www.globalinsightservices.com/reports/hemodialysis-and-peritoneal-dialysis-market/

The hemodialysis segment dominated the market with the highest revenue and CAGR during the projection period

Based on the type, it is segmented into hemodialysis and peritoneal dialysis. In 2021, the hemodialysis segment dominated the market with the highest revenue and CAGR during the projection period. The hemodialysis market is also further divided into nighttime hemodialysis and typical, brief daily hemodialysis. Continuous Ambulatory Peritoneal Dialysis (CAPD) and Ambulatory Peritoneal Dialysis are two further subgroups of peritoneal dialysis (APD). Significant market drivers include an increase in ESRD patients, a rise in the elderly population with kidney illnesses, and an increase in the frequency of diabetes and hypertension. The report World Population Ageing 2020 stated that 727 million individuals worldwide were 65 or older. By 2050, it is anticipated that the population will have more than doubled to around 1.5 billion people. The segment growth is anticipated to be greatly accelerated by the aging population and the increased risk of CKD.

The service segment is likely to dominate the market during the forecast period

Based on the product, it is segmented into devices, consumables, and services. The service segment is likely to dominate the market during the forecast period. This can be linked to an increase in the prevalence of ESRD and an increase in the number of dialysis service providers. Additionally, a number of significant dialysis service providers are attempting to diversify their service portfolios by opening and acquiring new dialysis facilities around the globe, which is anticipated to stimulate segment expansion. Numerous manufacturers’ activities and technological developments are anticipated to further accelerate market expansion. For instance, DaVita added a safe telehealth solution called DaVita Care Connect to its home dialysis business in February 2021. It was one of many connective technologies included in its offering of services with the goal of enhancing care and results for patients who decide to take care of themselves at home.

The hospital-based segment dominated the market with the highest market share and CAGR during the forecast period

Based on the end user, it is segmented into home-based and hospital-based. In 2021, the hospital-based segment dominated the market with the highest market share and CAGR during the forecast period. The substantial supply of highly skilled and seasoned healthcare staff at hospitals will likely allow the industry to maintain its lead over the coming years. In healthcare environments like hospitals and dialysis clinics, the presence of a qualified and experienced renal care team guarantees effective treatment and improved dialysis outcomes. The segment is expected to be driven by a number of factors, including the increasing emphasis on developing independent dialysis centers by companies and the rising uptake of in-center dialysis by patients. Additionally, businesses are concentrating on creating hemodialysis machines that can perform a range of interventions. The end-user experience is likely to be impacted by this.

North America dominated the market with the highest market share with the largest revenue in 2021

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America dominated the market with the highest market share with the largest revenue in 2021. The region’s market is expanding as a result of the existence of key players, large government investments in the creation of cutting-edge medical devices, and a favorable reimbursement environment. Dialysis is becoming more popular as a result of the increase in kidney failures and chronic kidney diseases (CKD). High disposable income, government initiatives, and rising healthcare spending are a few major reasons boosting the market.

Over the projected period, the Asia Pacific area is anticipated to have the greatest CAGR. Rising renal failure cases, an aging population, and increased product development are anticipated to fuel market expansion over the course of the projected period. In addition, the IDF estimates that 88 million adults in South East Asia currently have diabetes, with 153 million likely to have the disease by 2045. In addition, increased government initiatives, CKD awareness programs, technologically advanced products, the availability of newly built, state-of-the-art healthcare facilities in the area, and rising healthcare spending are a few other factors influencing market growth.

Recent Developments

May 2021, Mar Cor (Cantel Medical Corporation) announced the launch of its innovative EON Portable hemodialysis water system.
October 2020, Fresenius Medical Care AG & Co. KGaA announced the launch of a PVC-free peritoneal dialysis solution bag designed for dialysis therapy performed at home.
August 2020, Baxter International Inc. received FDA approval for De Novo application for Theranova dialyzers designed to deliver expanded hemodialysis (HDx) therapy.
January 2019, AWAK Technologies received FDA breakthrough designation for the company’s Peritoneal Dialysis Mix device, a wearable dialysis device used for patients suffering from kidney diseases.

Hemodialysis and Peritoneal Dialysis Market Report Coverage

The report offers a comprehensive quantitative as well as qualitative analysis of the current global Hemodialysis and Peritoneal Dialysis market outlook and estimations from 2021 to 2031, which helps to recognize the prevalent opportunities.
A thorough analysis of market trends and restraints is provided.
Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
The forecasts in this report are made by examining the recent trends along with future Hemodialysis and Peritoneal Dialysis market potential from 2021 to 2031 in terms of revenue.
Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Hemodialysis and Peritoneal Dialysis market are also analyzed.
Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global Hemodialysis and Peritoneal Dialysis industry.

Global Hemodialysis and Peritoneal Dialysis Market Segmentation

By Type